High-dose-rate interstitial brachytherapy for mucinous adenocarcinoma endocervical-type – a case study

Sylwia Kellas-Ślęczka; Brygida Białas; Marek Fijalkowski; Marta Szlag; Katarzyna Raczek-Zwierzycka

doi:10.17772/gp/1681

Vol 84, No 12 (2013)

ARTICLES

View PDF

Download PDF file

Get Citation

High-dose-rate interstitial brachytherapy for mucinous adenocarcinoma endocervical-type – a case study

Sylwia Kellas-Ślęczka, Brygida Białas, Marek Fijalkowski, Marta Szlag, Katarzyna Raczek-Zwierzycka

DOI: 10.17772/gp/1681

Ginekol Pol 2013;84(12).

Vol 84, No 12 (2013)

ARTICLES

Abstract

Background: Adenocarcinoma in cervical cancer has poorer response rate to treatment and requires longer time to achieve complete remission than squamous cell carcinoma [1]. Lower response to chemotherapy and radiotherapy is observed [2,3,4,5] and the optimal management remains undefined [1,4,6,7]. Case: We report a case of a 58-year-old woman with bulky mucinous adenocarcinoma endocervical-type G1, treated previously with radiochemotherapy with no visible response. After subsequent interstitial HDR brachytherapy (iHDR-BT) complete local remission was achieved. Conclusion: Interstitial HDR brachytherapy in bulky mucinous adenocarcinoma endocervical-type may be the best treatment choice that allows to receive a complete local response.